Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1192

1.

Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography.

Alfuraih AM, Tan AL, O'Connor P, Emery P, Mackie S, Wakefield RJ.

Int J Rheum Dis. 2019 Jul 30. doi: 10.1111/1756-185X.13667. [Epub ahead of print]

PMID:
31364284
2.

IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function.

Ridgley LA, Anderson AE, Maney NJ, Naamane N, Skelton AJ, Lawson CA, Emery P, Isaacs JD, Carmody RJ, Pratt AG.

Front Immunol. 2019 Jul 3;10:1535. doi: 10.3389/fimmu.2019.01535. eCollection 2019.

3.

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Mortimer I, Bissell LA, Hensor EMA, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Emery P, Morgan AW, Andrews J.

Rheumatology (Oxford). 2019 Apr 16. pii: kez114. doi: 10.1093/rheumatology/kez114. [Epub ahead of print] No abstract available.

PMID:
31329965
4.

Muscle stiffness in rheumatoid arthritis is not altered or associated with muscle weakness: A shear wave elastography study.

Alfuraih AM, Tan AL, O'Connor P, Emery P, Wakefield RJ.

Mod Rheumatol. 2019 Aug 1:1-9. doi: 10.1080/14397595.2019.1645374. [Epub ahead of print]

PMID:
31314615
5.

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.

Al-Laith M, Jasenecova M, Abraham S, Bosworth A, Bruce IN, Buckley CD, Ciurtin C, D'Agostino MA, Emery P, Gaston H, Isaacs JD, Filer A, Fisher BA, Huizinga TWJ, Ho P, Jacklin C, Lempp H, McInnes IB, Pratt AG, Östor A, Raza K, Taylor PC, van Schaardenburg D, Shivapatham D, Wright AJ, Vasconcelos JC, Kelly J, Murphy C, Prevost AT, Cope AP.

Trials. 2019 Jul 15;20(1):429. doi: 10.1186/s13063-019-3403-7.

6.

Normal values and test-retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle.

Farrow M, Grainger AJ, Tan AL, Buch MH, Emery P, Ridgway JP, Feiweier T, Tanner SF, Biglands J.

Br J Radiol. 2019 Jul 12:20190143. doi: 10.1259/bjr.20190143. [Epub ahead of print]

PMID:
31298948
7.

Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.

Ahmad HA, Baker JF, Østergaard M, Ye J, Emery P, Conaghan PG.

Adv Ther. 2019 Sep;36(9):2384-2393. doi: 10.1007/s12325-019-01020-6. Epub 2019 Jul 5.

8.

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.

Tanaka Y, Smolen JS, Jones H, Szumski A, Marshall L, Emery P.

Arthritis Res Ther. 2019 Jul 5;21(1):164. doi: 10.1186/s13075-019-1937-4.

9.

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Michaud K, Pope JE, Emery P, Zhu B, Gaich CL, DeLozier AM, Zhang X, Dickson CL, Smolen JS.

Rheumatol Ther. 2019 Sep;6(3):409-419. doi: 10.1007/s40744-019-0164-4. Epub 2019 Jun 21.

10.

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.

Taylor PC, Lee YC, Fleischmann R, Takeuchi T, Perkins EL, Fautrel B, Zhu B, Quebe AK, Gaich CL, Zhang X, Dickson CL, Schlichting DE, Patel H, Durand F, Emery P.

J Clin Med. 2019 Jun 12;8(6). pii: E831. doi: 10.3390/jcm8060831.

11.

Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.

Mankia K, Cheng Z, Do T, Hunt L, Meade J, Kang J, Clerehugh V, Speirs A, Tugnait A, Hensor EMA, Nam JL, Devine DA, Emery P.

JAMA Netw Open. 2019 Jun 5;2(6):e195394. doi: 10.1001/jamanetworkopen.2019.5394.

12.

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis.

van der Heijde D, Schiff M, Tanaka Y, Xie L, Meszaros G, Ishii T, Casillas M, Ortmann RA, Emery P.

RMD Open. 2019 May 10;5(1):e000898. doi: 10.1136/rmdopen-2019-000898. eCollection 2019. Erratum in: RMD Open. 2019 Jul 8;5(2):e000898corr1.

13.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

14.

Long-term drug survival of tumor necrosis factor inhibitors in patients with rheumatoid arthritis.

Emery P, Vlahos B, Szczypa P, Thakur M, Jones HE, Woolcott J, Estrella PVS, Rolland C, Gibofsky A, Citera G, Sockalingam S, Marshall L.

J Rheumatol. 2019 Jun 1. pii: jrheum.181398. doi: 10.3899/jrheum.181398. [Epub ahead of print]

PMID:
31154413
15.

Predicting severe infection and effects of hypogammaglobulinaemia during therapy with rituximab in rheumatic and musculoskeletal diseases.

Md Yusof MY, Vital EM, McElvenny DM, Hensor EMA, Das S, Dass S, Rawstron AC, Buch MH, Emery P, Savic S.

Arthritis Rheumatol. 2019 May 27. doi: 10.1002/art.40937. [Epub ahead of print]

PMID:
31131994
16.

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.

Smolen JS, Pangan AL, Emery P, Rigby W, Tanaka Y, Vargas JI, Zhang Y, Damjanov N, Friedman A, Othman AA, Camp HS, Cohen S.

Lancet. 2019 Jun 8;393(10188):2303-2311. doi: 10.1016/S0140-6736(19)30419-2. Epub 2019 May 23. Erratum in: Lancet. 2019 Jun 29;393(10191):2590.

PMID:
31130260
17.

Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al.

Mankia K, D'Agostino MA, Murillo-González J, Grainger A, Emery P.

Ann Rheum Dis. 2019 May 17. pii: annrheumdis-2019-215611. doi: 10.1136/annrheumdis-2019-215611. [Epub ahead of print] No abstract available.

18.

Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis.

Burska AN, Thu A, Parmar R, Bzoma I, Samans B, Raschke E, Olek S, Conaghan PG, Emery P, Ponchel F.

Rheumatology (Oxford). 2019 May 12. pii: kez162. doi: 10.1093/rheumatology/kez162. [Epub ahead of print]

PMID:
31081041
19.

Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study.

Emery P, Burmester GR, Bykerk VP, Combe BG, Furst DE, Maldonado MA, Huizinga TW.

RMD Open. 2019 Feb 8;5(1):e000840. doi: 10.1136/rmdopen-2018-000840. eCollection 2019.

20.

Nutrient, fibre, sorbitol and chlorogenic acid content of prunes (Prunus domestica): an updated analysis and comparison of different countries of origin and database values.

Gill SK, Lever E, Emery PW, Whelan K.

Int J Food Sci Nutr. 2019 Apr 16:1-8. doi: 10.1080/09637486.2019.1600664. [Epub ahead of print]

PMID:
30987487
21.

MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis.

Mankia K, D'Agostino MA, Rowbotham E, Hensor EM, Hunt L, Möller I, Miguel M, Mérida-Velasco JR, Murillo-González J, Naredo E, Nam JL, Tan AL, Freeston JE, Grainger A, Emery P.

Ann Rheum Dis. 2019 Jun;78(6):781-786. doi: 10.1136/annrheumdis-2018-214331. Epub 2019 Mar 23.

22.

First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.

Fent G, Mankia K, Erhayiem B, Hunt L, Nam JL, Bissell LA, Foley JR, Chew PG, Brown LE, Greenwood JP, Emery P, Plein S, Buch MH.

Ann Rheum Dis. 2019 Aug;78(8):1138-1140. doi: 10.1136/annrheumdis-2018-214975. Epub 2019 Mar 9. No abstract available.

23.

Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapy.

Calabrese LH, Emery P, Kivitz AJ, Tesser JRP.

Semin Arthritis Rheum. 2019 Jan 23. pii: S0049-0172(19)30030-7. doi: 10.1016/j.semarthrit.2019.01.008. [Epub ahead of print] No abstract available.

PMID:
30850126
24.

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Hensor EMA, McKeigue P, Ling SF, Colombo M, Barrett JH, Nam JL, Freeston J, Buch MH, Spiliopoulou A, Agakov F, Kelly S, Lewis MJ, Verstappen SMM, MacGregor AJ, Viatte S, Barton A, Pitzalis C, Emery P, Conaghan PG, Morgan AW.

Rheumatology (Oxford). 2019 Mar 1. pii: kez049. doi: 10.1093/rheumatology/kez049. [Epub ahead of print]

25.

Muscle shear wave elastography in idiopathic inflammatory myopathies: a case-control study with MRI correlation.

Alfuraih AM, O'Connor P, Tan AL, Hensor EMA, Ladas A, Emery P, Wakefield RJ.

Skeletal Radiol. 2019 Aug;48(8):1209-1219. doi: 10.1007/s00256-019-03175-3. Epub 2019 Feb 27.

26.

The effect of ageing on shear wave elastography muscle stiffness in adults.

Alfuraih AM, Tan AL, O'Connor P, Emery P, Wakefield RJ.

Aging Clin Exp Res. 2019 Feb 14. doi: 10.1007/s40520-019-01139-0. [Epub ahead of print]

27.

Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.

Bykerk VP, Burmester GR, Combe BG, Furst DE, Huizinga TWJ, Ahmad HA, Emery P.

Rheumatol Int. 2019 May;39(5):945. doi: 10.1007/s00296-018-4232-9.

28.

Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar.

Kay J, Dörner T, Emery P, Kvien TK, Breedveld FC.

Ann Rheum Dis. 2019 Jan 18. pii: annrheumdis-2018-214994. doi: 10.1136/annrheumdis-2018-214994. [Epub ahead of print] No abstract available.

29.

MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis.

Peterfy C, DiCarlo J, Emery P, Genovese MC, Keystone EC, Taylor PC, Schlichting DE, Beattie SD, Luchi M, Macias W.

J Rheumatol. 2019 Aug;46(8):887-895. doi: 10.3899/jrheum.171469. Epub 2019 Jan 15.

30.

Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus.

Mahmoud K, Zayat AS, Yusof Y, Hensor E, Conaghan PG, Emery P, Vital EM.

Rheumatology (Oxford). 2019 Jan 3. doi: 10.1093/rheumatology/key422. [Epub ahead of print]

31.

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.

Emery P, Rondon J, Parrino J, Lin Y, Pena-Rossi C, van Hoogstraten H, Graham NMH, Liu N, Paccaly A, Wu R, Spindler A.

Rheumatology (Oxford). 2018 Dec 19. doi: 10.1093/rheumatology/key361. [Epub ahead of print]

32.

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.

Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, Talloczy Z, Porter B.

Rheumatology (Oxford). 2018 Dec 19. doi: 10.1093/rheumatology/key375. [Epub ahead of print]

33.

Guided inquiry activity linking thermodynamic parameters of protein unfolding to structure using differential scanning fluorimetry data in the biophysical chemistry classroom.

Emery P, Yezierski EJ, Page RC.

Biochem Mol Biol Educ. 2019 Jan;47(1):67-75. doi: 10.1002/bmb.21198. Epub 2018 Dec 22.

PMID:
30578703
34.

Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al.

Mankia K, D'Agostino MA, Emery P.

Ann Rheum Dis. 2018 Dec 21. pii: annrheumdis-2018-214867. doi: 10.1136/annrheumdis-2018-214867. [Epub ahead of print] No abstract available.

35.

Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study.

Savage L, Goodfield M, Horton L, Watad A, Hensor E, Emery P, Wakefield R, Wittmann M, McGonagle D.

Arthritis Rheumatol. 2019 Apr;71(4):626-631. doi: 10.1002/art.40778. Epub 2019 Mar 4.

PMID:
30468001
36.

Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities.

Baraliakos X, Conaghan PG, D'Agostino MA, Maksymowych W, Naredo E, Ostergaard M, Schett G, Emery P.

Eur J Rheumatol. 2019 Jan;6(1):38-47. doi: 10.5152/eurjrheum.2018.18121. Review.

37.

Safety evaluation of adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view.

Duquenne L, Gul H, Emery P.

Expert Opin Drug Saf. 2019 Jan;18(1):11-19. doi: 10.1080/14740338.2018.1549541. Epub 2018 Dec 17. Review.

PMID:
30444672
38.

Recent advances in ankylosing spondylitis: understanding the disease and management.

Garcia-Montoya L, Gul H, Emery P.

F1000Res. 2018 Sep 21;7. pii: F1000 Faculty Rev-1512. doi: 10.12688/f1000research.14956.1. eCollection 2018. Review.

39.

On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.

Bykerk VP, Burmester GR, Combe BG, Furst DE, Huizinga TWJ, Ahmad HA, Emery P.

Rheumatol Int. 2018 Dec;38(12):2225-2231. doi: 10.1007/s00296-018-4173-3. Epub 2018 Oct 20. Erratum in: Rheumatol Int. 2019 Feb 5;:.

40.

Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism.

Mankia K, D'Agostino MA, Wakefield RJ, Nam JL, Mahmood W, Grainger AJ, Emery P.

Ann Rheum Dis. 2019 Jan;78(1):43-50. doi: 10.1136/annrheumdis-2018-214175. Epub 2018 Oct 8.

41.

Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features.

El-Sherbiny YM, Psarras A, Md Yusof MY, Hensor EMA, Tooze R, Doody G, Mohamed AAA, McGonagle D, Wittmann M, Emery P, Vital EM.

Sci Rep. 2018 Oct 1;8(1):14846. doi: 10.1038/s41598-018-33062-1.

42.

Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus.

Zayat AS, Mahmoud K, Md Yusof MY, Mukherjee S, D'Agostino MA, Hensor EMA, Wakefield RJ, Conaghan PG, Edwards CJ, Emery P, Vital EM.

Rheumatology (Oxford). 2019 Feb 1;58(2):304-312. doi: 10.1093/rheumatology/key277.

PMID:
30265343
43.

European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.

Abignano G, Blagojevic J, Bissell LA, Dumitru RB, Eng S, Allanore Y, Avouac J, Bosello S, Denton CP, Distler O, Ferraccioli G, Jordan S, Matucci-Cerinic M, Ong V, Messenger M, Hutchinson M, Buch MH, Emery P, Del Galdo F.

Rheumatology (Oxford). 2019 Feb 1;58(2):254-259. doi: 10.1093/rheumatology/key271.

PMID:
30239834
44.

What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?

Coates LC, Lubrano E, Perrotta FM, Emery P, Conaghan PG, Helliwell PS.

J Rheumatol. 2019 Jan;46(1):38-42. doi: 10.3899/jrheum.180267. Epub 2018 Sep 15.

PMID:
30219765
45.

Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review.

Emery P, Pope JE, Kruger K, Lippe R, DeMasi R, Lula S, Kola B.

Adv Ther. 2018 Oct;35(10):1535-1563. doi: 10.1007/s12325-018-0757-2. Epub 2018 Aug 20. Review.

46.

Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis.

Tanaka Y, McInnes IB, Taylor PC, Byers NL, Chen L, de Bono S, Issa M, Macias WL, Rogai V, Rooney TP, Schlichting DE, Zuckerman SH, Emery P.

Arthritis Rheumatol. 2018 Dec;70(12):1923-1932. doi: 10.1002/art.40680. Epub 2018 Oct 22.

47.

Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status.

Md Yusof MY, Psarras A, El-Sherbiny YM, Hensor EMA, Dutton K, Ul-Hassan S, Zayat AS, Shalbaf M, Alase A, Wittmann M, Emery P, Vital EM.

Ann Rheum Dis. 2018 Oct;77(10):1432-1439. doi: 10.1136/annrheumdis-2018-213386. Epub 2018 Jun 21.

48.

Reconfiguration of a Multi-oscillator Network by Light in the Drosophila Circadian Clock.

Chatterjee A, Lamaze A, De J, Mena W, Chélot E, Martin B, Hardin P, Kadener S, Emery P, Rouyer F.

Curr Biol. 2018 Jul 9;28(13):2007-2017.e4. doi: 10.1016/j.cub.2018.04.064. Epub 2018 Jun 14.

49.

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.

Brown S, Everett CC, Naraghi K, Davies C, Dawkins B, Hulme C, McCabe C, Pavitt S, Emery P, Sharples L, Buch MH.

Health Technol Assess. 2018 Jun;22(34):1-280. doi: 10.3310/hta22340.

50.

Neural Network Interactions Modulate CRY-Dependent Photoresponses in Drosophila.

Lamba P, Foley LE, Emery P.

J Neurosci. 2018 Jul 4;38(27):6161-6171. doi: 10.1523/JNEUROSCI.2259-17.2018. Epub 2018 Jun 6.

Supplemental Content

Support Center